Silvant Capital Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-3,362
| Closed | -$139K | – | 346 |
|
|
2022
Q3 | $139K | Hold |
3,362
| – | – | 0.01% | 223 |
|
|
2022
Q2 | $201K | Hold |
3,362
| – | – | 0.05% | 152 |
|
|
2022
Q1 | $244K | Hold |
3,362
| – | – | 0.05% | 156 |
|
|
2021
Q4 | $283K | Sell |
3,362
-216
| -6% | -$18.2K | 0.05% | 156 |
|
|
2021
Q3 | $323K | Hold |
3,578
| – | – | 0.06% | 148 |
|
|
2021
Q2 | $341K | Hold |
3,578
| – | – | 0.05% | 147 |
|
|
2021
Q1 | $407K | Hold |
3,578
| – | – | 0.07% | 135 |
|
|
2020
Q4 | $495K | Hold |
3,578
| – | – | 0.08% | 124 |
|
|
2020
Q3 | $294K | Sell |
3,578
-992
| -22% | -$81.5K | 0.06% | 149 |
|
|
2020
Q2 | $357K | Hold |
4,570
| – | – | 0.06% | 130 |
|
|
2020
Q1 | $203K | Hold |
4,570
| – | – | 0.04% | 152 |
|
|
2019
Q4 | $195K | Hold |
4,570
| – | – | 0.04% | 183 |
|
|
2019
Q3 | $196K | Hold |
4,570
| – | – | 0.04% | 175 |
|
|
2019
Q2 | $290K | Hold |
4,570
| – | – | 0.05% | 161 |
|
|
2019
Q1 | $317K | Hold |
4,570
| – | – | 0.06% | 149 |
|
|
2018
Q4 | $199K | Hold |
4,570
| – | – | 0.04% | 177 |
|
|
2018
Q3 | $349K | Hold |
4,570
| – | – | 0.04% | 150 |
|
|
2018
Q2 | $351K | Hold |
4,570
| – | – | 0.04% | 147 |
|
|
2018
Q1 | $233K | Buy |
+4,570
| New | +$233K | 0.03% | 187 |
|